✦ LIBER ✦

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

✍ Scribed by Y. P. M. Goekoop-Ruiterman; J. K. De Vries-Bouwstra; C. F. Allaart; D. Van Zeben; P. J. S. M. Kerstens; J. M. W. Hazes; A. H. Zwinderman; H. K. Ronday; K. H. Han; M. L. Westedt; A. H. Gerards; J. H. L. M. Van Groenendael; W. F. Lems; M. V. Van Krugten; F. C. Breedveld; B. A. C. Dijkmans

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 242 KB
Volume: 52
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.21405

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement in work place and household

Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: Work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study

✍ Ronald F. van Vollenhoven; Mary A. Cifaldi; Saurabh Ray; Naijun Chen; Michael H. 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 167 KB 👁 2 views

Combination of infliximab and methotrexa

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

✍ E. William St. Clair; Désirée M. F. M. van der Heijde; Josef S. Smolen; Ravinder 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

## Abstract ## Objective To compare the benefits of initiating treatment with methotrexate (MTX) and infliximab (anti–tumor necrosis factor α [anti‐TNFα] monoclonal antibody) with those of MTX treatment alone in patients with rheumatoid arthritis (RA) of ≤3 years' duration. ## Methods RA patient

Radiographic, clinical, and functional o

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo-controlled, 52-week trial

✍ Edward C. Keystone; Arthur F. Kavanaugh; John T. Sharp; Hyman Tannenbaum; Ye Hua 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

Tumor necrosis factor therapy and the ri

Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: A meta-analysis of randomized controlled trials

✍ Andrew E. Thompson; Scott W. Rieder; Janet E. Pope 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

Comparison of etanercept and methotrexat

Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial

✍ Désirée van der Heijde; Lars Klareskog; Vicente Rodriguez-Valverde; Catalin Codr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 2 views

Evidence of radiographic benefit of trea

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

✍ J. S. Smolen; C. Han; M. Bala; R. N. Maini; J. R. Kalden; D. van der Heijde; F. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views